l 691121 has been researched along with Myocardial Infarction in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Appleby, SD; Baskin, EP; Bear, CM; Gehret, JR; Kothstein, T; Lynch, JJ; Sanguinetti, MC; Stupienski, RF; Van der Gaag, LH; Wallace, AA | 1 |
1 other study(ies) available for l 691121 and Myocardial Infarction
Article | Year |
---|---|
Cardiac electrophysiologic and antiarrhythmic actions of 3,4-dihydro-1'-[2-(benzofurazan-5-yl) ethyl]-6-methanesulfonamidospiro [(2H)-1-benzopyran-2,4'-piperidin]-4-one HCl (L-691,121), a novel class III agent.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Function; Cells, Cultured; Dogs; Electrophysiology; Ferrets; Guinea Pigs; Heart Atria; Heart Ventricles; In Vitro Techniques; Male; Myocardial Infarction; Myocardial Ischemia; Piperidones; Spiro Compounds; Ventricular Function | 1993 |